Skip to NavigationSkip to content

Moderna Therapeutics

Moderna Therapeutics names Dr John Medlein as new President, Corporate and Product Strategy

Published on: 04/01/18

Messenger RNA (mRNA) therapeutics and vaccines specialist Moderna Therapeutics has announced the appointment of current board member Dr John Medlein as its new President of Corporate and Product Strategy, where he will manage a range of responsibilities including product advancement and strategy, partnering and product protection, and corporate strategy.

Moderna Therapeutics instates MIT Treasurer to Board of Directors

Published on: 27/02/17

Moderna Therapeutics, a clinical stage biotechnology company, has announced the appointment of Israel Ruiz to the company’s Board of Directors. Israel Ruiz is currently the Executive Vice President and Treasurer at the Massachusetts Institute of Technology (MIT).

AstraZeneca and MedImmune in oncology research deals

Credit: MedImmune

AstraZeneca and its biologics arm MedImmune are launching new agreements with partner companies, to develop new targets for cancer, and to trial existing lung cancer drugs.

The first deal, with Moderna Therapeutics, will see the UK firms in a collaboration to discover, co-develop and co-commercialise messenger RNA (mRNA) therapeutic candidates for a range of cancers.

Moderna Therapeutics hires Goldman Sachs head

Published on: 11/03/14

Drug development biotech firm Moderna Therapeutics has hired Dr Lorence Kim to join its executive leadership team as chief financial officer.

Prior to joining the company Kim was managing director and co-head of the US biotech investment banking effort at Goldman Sachs. Whilst there Kim was a member of the Healthcare Investment Banking group for nearly 14 years and was named a managing director in 2008.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches